2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068084, P30CA015083, 979202, MAYO-979202, NCI-P00-0163, NCT00006219
|
3.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000653162, WSU-2008-012, 2008-012, NCT00972023
|